A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
CMAJ Highlights Treatment of community-acquired Should children be prescribed statins? pneumonia MacDonald, Stanbrook and Rieder question the wisdom of Fluoroquinolones, β-lactams prescribing statins to children based on limited evidence. See Du Cane Medical Imaging Ltd/Science Photo Library and macrolides are all Editorial, page 1239 highly effective for the treat- ment of pneumonia in adults, according to a meta- Canadian stroke guidelines, 2008 analysis based on 23 ran- domized controlled trials. A supplement to this issue documents the “best practice” rec- Vardakas and colleagues re- ommendations from the Canadian Stroke Network for the care port that fluoroquinolones, of patients with stroke. The full version of the guidelines is compared with β-lactams available at www.cmaj.ca/content/vol179/issue12/#supplement. and macrolides, were associ- In this issue, Bayley and colleagues highlight new evidence in ated with higher success for stroke care that was incorporated into their recommendations. treatment of severe pneumonia in open-label trials. See Re- See Commentary, page 1247 search, page 1269 Community-acquired pneumonia should be treated with a fluoroquinolone or a combination of a macrolide and a β- Health care reform in Chile lactam antibiotic, says Low. See Commentary, page 1245 A new plan establishes a list of 56 health conditions for which coverage and treatment are guaranteed by law. See Analysis, Folic acid antagonists
Pages to are hidden for
"HIGHLIGHTS"Please download to view full document